VONOPRAZAN
Endoscopic Variceal Band Ligation
King George's Medical UniversitySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Endoscopic Variceal Band Ligation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PROPRANOLOL West China Hospital | Phase 4 | BBB |
CARVEDILOL West China Hospital | Phase 4 | BBB |
Octreotide Pamoate Shanghai Zhongshan Hospital | Phase 4 | BB |
GLY-GLY-GLY-CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (4-9 DISULFIDE) General Hospital of Shenyang Military Region | Phase 4 | BB |
Octreotide Pamoate Shanghai Zhongshan Hospital | Phase 4 | BB |
View all 21 →
Same molecule, other indications
VONOPRAZAN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →